Status:
COMPLETED
Safety Study of Transdermal Testosterone for Low Libido in Pre and Postmenopausal Women
Lead Sponsor:
University Potiguar
Collaborating Sponsors:
Universidade Federal do Ceara
Federal Institute of Science and Technology of Ceara
Conditions:
Sex Behavior
Eligibility:
FEMALE
18-89 years
Phase:
PHASE2
Brief Summary
Female sexual dysfunction (FSD) is an established side effect of Selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenalin reuptake inhibitors (SNRIs), causing symptoms such as loss o...
Detailed Description
Recent studies have reported an increase in the number of satisfactory sexual events recorded in a 4-week daily diary, as a primary outcome, and reduction in associated personal distress. There is al...
Eligibility Criteria
Inclusion
- a body mass index between 18 and 35 kg/m2
- diminished libido complaints
- no evidence of severe clinical depression
- participants in good health based on history and physical examination.
Exclusion
- a past history of neurological disorder
- recent psychiatric or systemic illness
- use of psychoactive medications
- alcohol excess consumption or any other drug abuse.
- women who had under gone treatment for cardiovascular disease, genital bleeding, acne, depression, dyspareunia or those who had received oral androgen therapy in the previous 3 months were excluded
- in addition women taking medications known to interfere with sex steroid metabolism were also excluded.
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02215434
Start Date
September 1 2009
End Date
August 1 2014
Last Update
August 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Potiguar
Natal, Rio Grande do Norte, Brazil, 59060